JAMES SALES: Open Payments
NPI 1902885569 · ROCK ISLAND, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,108 in 15 payments from 8 companies in 2025. Trend: 2023 $413 · 2024 $1,268 · 2025 $1,108
Food & beverage: $1,009Education: $99
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 2 | $219 |
| ABBVIE INC. | 7 | $206 |
| Neurocrine BioSciences, Inc. | 1 | $125 |
| Otsuka America Pharmaceutical, Inc. | 1 | $125 |
| Alkermes, Inc. | 1 | $125 |
| Axsome Therapeutics, Inc. | 1 | $125 |
| E.R. Squibb & Sons, L.L.C. | 1 | $123 |
| Lilly USA, LLC | 1 | $60 |
Products named: VRAYLAR, INGREZZA, ABILIFY ASIMTUFII, LYBALVI, Auvelity, COBENFY, AUSTEDO XR, KISUNLA.
Industry payments across IL — which companies pay providers there.
